Skip to main content

X 23 (Alfuzosin Hydrochloride Extended Release 10 mg)

Pill with imprint X 23 is White, Round and has been identified as Alfuzosin Hydrochloride Extended Release 10 mg. It is supplied by Aurobindo Pharma Limited.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class alpha-adrenoreceptor antagonists. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for X 23

Alfuzosin hydrochloride extended release 10 mg X 23

Alfuzosin Hydrochloride Extended Release

Imprint
X 23
Strength
10 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma Limited
National Drug Code (NDC)
65862-0249
Inactive Ingredients
carbomer homopolymer type B, silicon dioxide, calcium phosphate dibasic anhydrous, hydrogenated cottonseed oil, hypromellose 2208 (100 mPa.s), hypromellose 2910 (5 mPa.s), magnesium stearate, povidone k30, propylene glycol, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "X 23"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.